Trending Now
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Expands Partnership On Development of TNX-1800...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced that it has expanded its strategic partnership with Southern Research. The Expansion includes T-cell immune response study...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BioRestorative Therapies (NASDAQ: BRTX) Advances in Regenerative Medicine with ThermoStem® Licensing...
BioRestorative Therapies, Inc. (NASDAQ: BRTX) saw a significant rise in its stock performance today, closing the trading session at $1.9500 with a...
MAKE IT MODERN
LATEST REVIEWS
The Next Biotech Winners After the Vaccine Bubble Burst (ATRX, INMB,...
The Covid story is starting to change. And you can hear the popping sound in the vaccine space. The needle is “therapeutics”.
MAKE IT MODERN
PERFORMANCE TRAINING
Boon Industries (OTCMKTS:BNOW) Ramps Toward Potential Breakout as DiOx+ Gains Traction
The pandemic health crisis has activated investor interest in a number of different market sectors, with chemicals being one of the most...
Sugarmade Inc (OTCMKTS:SGMD) Could See Election Tailwind as Model Expands
As we have been noting, the big winner this election is Cannabis.
Voters moved to legalize weed in Arizona, Montana, New Jersey, and South Dakota....
Arca Biopharma Inc (NASDAQ: ABIO) Announces the Results for ASPEN-COVID-19
Arca Biopharma Inc (NASDAQ: ABIO) announced its ASPEN-COVID-19 results. The phase IIb study had 160 patients and investigated rNAPc, that treats patients with COVID-19....
Qualigen Therapeutics (NASDAQ:QLGN) Announce Expansion Of Research Agreement With the University Of Louisville for...
Qualigen Therapeutics Inc. (NASDAQ:QLGN) has announced the expansion of its Sponsored Research Agreement with the University of Louisville to advance Qualigen's Aptamer-linked Anti-Nucleolin (ALAN),...
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in genomic insights and improved health outcomes, has made significant strides in the first...
MAKE IT MODERN
